Journal of Viral Hepatitis

HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?
pp. 323-330(8)
Authors: Blackard, J. T.; Sherman, K. E.

Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection
pp. 331-338(8)
Authors: Gonzalez, S. A.; Zhang, C.; Fiel, M. I.; Chung, S.; Zhang, L.; Jacobson, I. M.; Talal, A. H.

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease
pp. 339-345(7)
Authors: Hamed, M. R. B.; Tarr, A. W.; McClure, C. P.; Ball, J. K.; Hickling, T. P.; Irving, W. L.

Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2
pp. 346-356(11)
Authors: Pérez-Berná, A. J.; Veiga, A. S.; Castanho, M. A. R. B.; Villalaín, J.

Modelling hepatitis C virus kinetics during treatment with pegylated interferon α-2b: errors in the estimation of viral kinetic parameters
pp. 357-362(6)
Authors: Shudo, E.; Ribeiro, R. M.; Perelson, A. S.

Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
pp. 363-369(7)
Authors: Núñez, M.; Ocampo, A.; Aguirrebengoa, K.; Cervantes, M.; Pascual, A.; Echeverria, S.; Asensi, V.; Barreiro, P.; Garcia-Samaniego, J.; Soriano, V.

A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment
pp. 370-378(9)
Authors: Younossi, Z. M.; Nader, F. H.; Bai, C.; Sjogren, R.; Ong, J. P.; Collantes, R.; Sjogren, M.; Farmer, D.; Ramsey, L.; Terra, K.; Gujral, H.; Gurung, C.; Srishord, M.; Fang, Y.

Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b
pp. 379-382(4)
Authors: Shudo, E.; Ribeiro, R. M.; Perelson, A. S.

Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5
pp. 383-386(4)
Authors: Antaki, N.; Hermes, A.; Hadad, M.; Ftayeh, M.; Antaki, F.; Abdo, N.; Kebbewar, K.

MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma
pp. 387-391(5)
Authors: Segat, L.; Fabris, A.; Padovan, L.; Milanese, M.; Pirulli, D.; Lupo, F.; Salizzoni, M.; Amoroso, A.; Crovella, S.

Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B
pp. 392-398(7)
Authors: Gallego, A.; Sheldon, J.; García-Samaniego, J.; Margall, N.; Romero, M.; Hornillos, P.; Soriano, V.; Enríquez, J.